Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles?

Virology

Volumn 229, Issue 1, 1997, Pages 1-11

  Lamb, Robert A ^a   Pinto, Lawrence H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL;

ELECTROPHYSIOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS B; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN INFLUENZA VIRUS; INFLUENZA B VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS B;

EID: 0031550769     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8451     Document Type: Article

References (127)

1. Albuquerque, E. X., Eldefrawi, A. T., Eldefrawi, M. E., Mansour, N. A., and Tsai, M.-C. (1978). Amantadine: Neuromuscular blockade by suppression of ionic conductance of the acetylcholine receptor. Science 199, 788-790.
2. Arroyo, J., Boceta, M., Gonzalez, M. A., Michel, M., and Carrasco, L. (1995). Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41. J. Virol. 69, 4095-4102.
3. Ashcroft, F. M., Kerr, A. J., Gibson, J. S., and Williams, B. A. (1991). Amantadine and sparteine inhibit ATP-regulated K-currents in the insulin-secreting β-cell line, HIT-T15. Br. J. Pharmacol. 104, 579-584.
4. - channels. Nature 365, 850-852.
5. Bahraoni, E., Benjouad, A., Guetard, D., Kolbe, H., Gluckman, J. C., and Montagnier, L. (1992). Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans. AIDS Res. Hum. Retroviruses 8, 565-573.
6. Bartz, S., Rogel, M. E., and Emerman, M. (1996). Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70, 2324-2331.
7. Betakova, T., Nermut, M. V., and Hay, A. J. (1996). The NB protein is an integral component of the membrane of influenza B virus. J. Gen. Virol. 77, 2689-2694.
8. Bouhamdan, M., Benichou, S., Rey, F., Navarro, J. M., Agostini, I., Spire, B., Camonis, J., Slupphaus, G., Vigne, R., Benarous, R., and Sire, J. (1996). Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70, 697-704.
9. Bour, S., Boulerice, F., and Wainberg, M. A. (1991). Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. J. Virol. 65, 6387-6396.
10. Bour, S., Schubert, U., Peden, K., and Strebel, K. (1996). The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: A Vpu-like factor? J. Virol. 70, 820-829.
11. Bour, S., Schubert, U., and Strebel, K. (1995). The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: Implications for the mechanism of degradation. J. Virol. 69, 1510-1520.
12. Bour, S., and Strebel, K. (1996). The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J. Virol. 70, 8285-8300.
13. Brassard, D. L., Leser, G. P., and Lamb, R. A. (1996). Influenza B virus NB glycoprotein is a component of virions. Virology 220, 350-360.
14. Bresink, I., Danysz, W., Parsons, C. G., and Mutschler, E. (1995). Different binding affinities of NMDA receptor channel blockers in various brain regions - Indication of NMDA receptor heterogeneity. Neuropharmacology 34, 533-540.
15. 1) of influenza A and B viruses and conservation of a second open reading frame. Virology 116, 581-588.
16. 1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J. Virol. 70, 8391-8401.
17. Bukrinskaya, A. G., Vorkunova, N. K., Kornilayeva, G. V., Narmanbetova, R. A., and Vorkunova, G. K. (1982). Influenza virus uncoating in infected cells and effects of rimantadine. J. Gen. Virol. 60, 49-59.
18. Bukrinsky, M. I., Haggerty, S., Dempsey, M. P., Sharova, N., Adzhubei, A., Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., and Stevenson, M. (1993). A nuclear targeting signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666-669.
19. Buonocore, L., and Rose, J. K. (1990). Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 345, 625-628.
20. Carrasco, L. (1995). Modification of membrane permeability by animal viruses. Adv. Virus Res. 45, 61-112.
21. Chernomordik, L., Chanturiya, A. N., Suss-Toby, E., Nora, E., and Zimmerberg, J. (1994). An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 68, 7115-7123.
22. 2 channel expressed in mouse erythroleukaemia cells. J. Physiol. 494, 329-336.
23. Christiansen, B., Fink, J., Merrifield, R. B., and Mazerall, D. (1988). Channel forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc. Natl. Acad. Sci. USA 85, 5072-5076.
24. 2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment. Virology 188, 14-24.
25. 2 protein of influenza A viruses. Virus Res. 22, 247-258.
26. Cohen, E. A., Terwilliger, E. F., Jalinoos, Y., Proulx, J., Sodroski, J. G., and Haseltine, W. A. (1990). Identification of HIV-1 vpr product and function. J. Acq. Immune Def. Syndr. 3, 11-18.
27. Cohen, E. A., Terwilliger, E. F., Sodroski, J. G., and Haseltine, W. A. (1988). Identification of a protein encoded by the vpu gene of HIV-1. Nature 334, 532-534.
28. Crise, B., Buonocore, L., and Rose, J. K. (1990). CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J. Virol. 64, 5585-5593.
29. Davies, W. L., Grunert, R. R., Haff, R. F., McGahen, J. W., Neumayer, E. M., Paulshock, M., Watts, J. C., Wood, T. R., Herman, E. C., and Huffman, C. E. (1964). Antiviral activity of 1-adamantanamine (amantadine). Science 144, 862-863.
30. Di Marzio, P., Choe, S., Ebright, M., Knoblauch, R., and Landau, N. R. (1995). Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69, 7909-7916.
31. Doms, R. W., Lamb, R. A., Rose, J. K., and Helenius, A. (1993). Folding and assembly of viral membrane proteins. Virology 193, 545-562.
32. Duclohier, H., Molle, G., and Spach, G. (1989). Antimicrobial peptide magainin I from Xenopus skin forms anion permeable channels in planar lipid bilayers. Biophys. J. 56, 1017-1021.
33. 2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology 190, 485-489.
34. Emerman, M. (1996). HIV-1, Vpr and the cell cycle. Curr. Biol. 6, 1096-1103.
35. Ewart, G. D., Sutherland, T., Gage, P. W., and Cox, G. B. (1996). The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J. Virol. 70, 7108-7115.
36. Federau, T., Schubert, U., Floßdorf, J., Henklein, P., Schomburg, D., and Wray, V. (1996). Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu). Int. J. Pept. Protein Res. 47, 297-310.
37. Friborg, J., Ladha, A., Gottlinger, H., Haseltine, W. A., and Cohen, E. A. (1995). Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J. Acq. Immune Def. Syndr. Hum. Retrovirol. 8, 10-22.
38. Gallay, P., Stitt, V., Mundy, C., Oettinger, M., and Trono, D. (1996). Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70, 1027-1032.
39. Gallay, P., Swingler, S., Aiken, C., and Trono, D. (1995). HIV-1 infection of non-dividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80, 379-388.
40. Gottlinger, H. G., Dorfman, T., Cohen, E. A., and Haseltine, W. A. (1993). Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA 90, 7381-7385.
41. 2 protein of influenza A viruses. Virology 191, 541-549.
42. 2 protein. Virology 190, 11-18.
43. 2 protein modifies membrane permeability in E. coli cells. FEBS Lett. 343, 242-246.
44. 2 ion channel protein. Semin. Virol. 3, 21-30.
45. Hay, A. J., Wolstenholme, A. J., Skehel, J. J., and Smith, M. H. (1985). The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4, 3021-3024.
46. cdc2 activity. J. Virol. 69, 6705-6711.
47. Heinzinger, N., Bukrinsky, M., Haggerty, S., Ragland, A., Kewal Ramani, V., Lee, M., Gendelman, H., Ratner, L., Stevenson, M., and Emerman, M. (1994). The HIV-1 Vpr protein influences nuclear targeting of viral nucleic acids in non-dividing cells. Proc. Natl. Acad. Sci. USA 91, 7311-7315.
48. Helenius, A. (1992). Unpacking the incoming influenza virus. Cell 69, 577-578.
49. 2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 183, 32-43.
50. 2 ion channel protein: A structure-function analysis. J. Virol. 68, 1551-1563.
51. 2 protein. J. Virol. 69, 1219-1225.
52. Huet, T., Cheynier, R., Meyerhans, A., Roelants, G., and Wain-Hobson, S. (1990). Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature 345, 356-359.
53. Ivey-Hoyle, M., Gulp, J. S., Chaikin, M. A., Hellmig, B. D., Matthews, T. J., Sweet, R. W., and Posenberg, M. (1991). Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc. Natl. Acad. Sci. USA 88, 512-516.
54. Jabbar, M. A., and Nayak, D. P. (1990). Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J. Virol. 64, 6291-6304.
55. Jowett, J. B. M., Planelles, V., Poon, B., Shah, N. P., Chen, M.-L., and Chen, I. S. Y. (1995). The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69, 6304-6313.
56. Klimkait, T., Strebel, K., Hoggan, M. D., Martin, M. A., and Orenstein, J. M. (1990). The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64, 621-629.
57. gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 69, 2759-2764.
58. 2 protein in Saccharomyces cerevisiae: Identification of a novel inhibitor of influenza virus. Antimicrob. Agents Chem. 39, 2204-2209.
59. 2) encoded by RNA segment 7 of influenza virus. Virology 112, 729-737.
60. 2 ion channel protein and its role in the influenza virus life cycle. In "Receptor-Mediated Virus Entry into Cells" (E. Wimmer, Ed.), pp. 303-321. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
61. 2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40, 627-633.
62. Lavallee, C., Yao, X. J., Ladha, A., Gottlinger, H., Haseltine, W. A., and Cohen, E. A. (1994). Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J. Virol. 68, 1926-1934.
63. Lear, J. D., Wasserman, Z. R., and DeGrado, W. F. (1988). Synthetic amphiphilic peptide models for protein ion channels. Science 240, 1179-1181.
64. Lenberg, M. E., and Landau, N. R. (1993). Vpu-induced degradation of CD4: Requirement of specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67, 7238-7245.
65. Levy, D. N., Fernandes, L. S., Williams, W. V., and Weiner, D. B. (1993). Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72, 541-550.
66. gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J. Virol. 69, 6873-6879.
67. Lu, Y. L., Spearman, P., and Ratner, L. (1993). Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67, 6542-6550.
68. Mahalingam, S., Khan, S. A., Murali, R., Jabbar, M. A., Monken, C. E., Collman, R. G., and Srinivasan, A. (1995). Mutagenesis of the putative α-helical domain of the Vpr protein of human immunodeficiency virus type 1: Effect on stability and virion incorporation. Proc. Natl. Acad. Sci. USA 92, 3794-3798.
69. Maldarelli, F., Chen, M.-Y., Willey, R. L., and Strebel, K. (1993). Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67, 5056-5061.
70. Martin, K., and Helenius, A. (1991). Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell 67, 117-130.
71. Mellman, I., Fuchs, R., and Helenius, A. (1986). Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55, 663-700.
72. Mulligan, M. J., Ritter, G. D., Jr., Chaikin, M. A., Yamshchikov, G. V., Kumar, P., Hahn, B. H., Sweet, R. W., and Compans, R. W. (1992). Human immunodeficiency virus type 2 envelope glycoprotein: Differential CD4 interactions of soluble gp120 versus the assembled envelope complex. Virology 187, 233-241.
73. Mustafa, F., and Robinson, H. L. (1993). Context-dependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers. J. Virol. 67, 6909-6915.
74. 2 protein. J. Virol. 68, 920-926.
75. Paxton, W., Connor, T. I., and Landau, N. R. (1993). Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67, 7229-7237.
76. Piller, S. C., Ewart, G. D., Premkumar, A., Cox, G. B., and Gage, P. W. (1996). Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc. Natl. Acad. Sci. USA 93, 111-115.
77. 2 protein has ion channel activity. Cell 69, 517-528.
78. Planelles, V., Bachelerie, R., Jowett, J. B. M., Haislip, A., Xie, Y. P. B., Masuda, T., and Chen, I. S. Y. (1995). Fate of the human immunodeficiency virus type 1 provirus in infected cells: A role for vpr. J. Virol. 69, 5883-5889.
79. Planelles, V., Jowett, J. B., Li, Q., Xie, Y., Hahn, B., and Chen, I. S. Y. (1996). Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70, 2516-2524.
80. cdc2-cyclin B. J. Virol. 69, 6859-6864.
81. Refaeli, Y., Levy, D. N., and Weiner, D. B. (1995). The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc. Natl. Acad. Sci. USA 92, 3621-3625.
82. Ritter, G. D., Jr., Yamshchikov, G., Cohen, S. J., and Mulligan, M. J. (1996). Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: Role of the cytoplasmic domain. J. Virol. 70, 2669-2673.
83. Rogel, M., Wu, L., and Emerman, M. (1995). The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69, 882-888.
84. 2 protein affects transport through the Golgi apparatus. J. Cell Biol. 133, 733-747.
85. 2 ion channel is a tetramer. Submitted.
86. Sansom, M. S. P. (1991). The biophysics of peptide models of ion channels. Prog. Biophys. Mol. Biol. 55, 139-235.
87. 2 protein expressed by baculovirus: Evidence for proton transfer activity. J. Gen. Virol. 75, 3477-3484.
88. Schubert, U., Bour, S., Ferrer-Montiel, A. V., Montal, M., Maldarelli, F., and Strebel, K. (1996a). The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70, 809-819.
89. Schubert, U., Clouse, K. A., and Strebel, K. (1995). Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69, 7699-7711.
90. Schubert, U., Ferrer-Montiel, A. V., Oblatt-Montal, M., Henklein, P., Strebel, K., and Montal, M. (1996b). Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 398, 12-18.
91. Schubert, U., Henklein, P., Boldyreff, B., Wingender, E., Strebel, K., and Porstmann, T. (1994). The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J. Mol. Biol. 236, 16-25.
92. Schubert, U., and Strebel, K. (1994). Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68, 2260-2271.
93. Shaw, M. W., and Choppin, P. W. (1984). Studies on the synthesis of the influenza B virus NB glycoprotein. Virology 139, 178-184.
94. Shaw, M. W., Choppin, P. W., and Lamb, R. A. (1983). A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc. Natl. Acad. Sci. USA 80, 4879-4883.
95. Shaw, M. W., Lamb, R. A., Erickson, B. W., Briedis, D. J., and Choppin, P. W. (1982). Complete nucleotide sequence of the neuraminidase gene of influenza B virus. Proc. Natl. Acad. Sci. USA 79, 6817-6821.
96. Shimbo, K., Brassard, D. L., Lamb, R. A., and Pinto, L. H. (1995). Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes. Biophys. J. 69, 1819-1829.
97. 2 ion channel of influenza virus. Biophys. J. 70, 1335-1346.
98. Strebel, K., Klimkait, T., Maldarelli, F., and Martin, M. A. (1989). Molecular and biochemical analyses of human immunodeficiency virus type 1 Vpu protein. J. Virol. 63, 3784-3791.
99. Strebel, K., Klimkait, T., and Martin, M. A. (1988). A novel gene of HIV-1, VPU, and its 16-kilodalton product. Science 241, 1221-1223.
100. Sugrue, R. J., Bahadur, G., Zambon, M. C., Hall-Smith, M., Douglas, A. R., and Hay, A. J. (1990). Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J. 9, 3469-3476.
101. 2 protein of the influenza A viruses: Evidence that it forms a tetrameric channel. Virology 180, 617-624.
102. Sunstrom, N. A., Premkumar, L. S., Premkumar, A., Ewart, G., Cox, G. B., and Gage, P. W. (1996). Ion channels formed by NB, an influenza B virus protein. J. Membr. Biol. 150, 127-132.
103. 2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J. Virol. 68, 911-919.
104. Terwilliger, E. F., Cohen, E. A., Lu, Y. C., Sodroski, J. G., and Haseltine, W. A. (1989). Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. USA 86, 5163-5167.
105. Tosteson, M. T., Auld, D. S., and Tosteson, D. C. (1989). Voltage-gated channels formed in lipid bilayers by a positively charged segment of the Na-channel polypeptide. Proc. Natl. Acad. Sci. USA 86, 707-710.
106. Tosteson, M. T., Caulfield, M. P., Levy, J. J., Rosenblatt, M., and Tosteson, D. C. (1988). The synthetic precursor specific region of pre-proparathyroid hormone forms ion channels in lipid bilayers. Biosci. Rep. 8, 173-183.
107. 2 ion channel in lipid bilayers. J. Membr. Biol. 142, 117-126.
108. 2 ion channel activity by BL-1743, an inhibitor of influenza A virus. J. Virol. 70, 4246-4252.
109. Tzounopoulos, T., Maylie, J., and Adelman, J. P. (1995). Induction of endogenous channels by high levels of heterologous membrane proteins in Xenopus oocytes. Biophys. J. 69, 904-908.
110. Vincent, M. J., Raja, N. U., and Jabbar, M. A. (1993). Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: Role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J. Virol. 67, 5538-5549.
111. von Heijne, G. (1988). Transcending the impenetrable: How proteins come to terms with membranes. Biochim. Biophys. Acta 189, 239-242.
112. von Schwedler, U., Kornbluth, R. S., and Trono, D. (1994). The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91, 6992-6996.
113. 2 protein ion channel activity in mammalian cells. Virology 205, 133-140.
114. 2 ion channel of influenza virus: A role for the transmembrane domain histidine residue. Biophys. J. 69, 1363-1371.
115. 2 protein: Characterization of the amantadine block. J. Virol. 67, 5585-5594.
116. Wang, J. J., Lu, Y.-I., and Ratner, L. (1994b). Particle assembly and Vpr expression in human immunodeficiency virus type 1-infected cells demonstrated by immunoelectron microscopy. J. Gen. Virol. 75, 2607-2614.
117. Wang, L., Mukherjee, S., Ja, F., Narayan, O., and Zhao, L. J. (1995b). Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J. Biol. Chem. 270, 25564-25569.
118. Warnick, J. E., Maleque, M. A., Bakry, N., Eldefrawi, A. T., and Albuquerque, E. X. (1982). Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channel of nicotinic acetylcholine receptor and electrically excitable membrane. Mol. Pharmacol. 22, 82-93.
119. Willey, R. L., Maldarelli, F., Martin, M. A., and Strebel, K. (1992a). Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193-7200.
120. Willey, R. L., Maldarelli, F., Martin, M. A., and Strebel, K. (1992b). Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66, 226-234.
121. 2-terminal region. Mol. Cell. Biol. 6, 4317-4328.
122. 1H NMR spectroscopy. Int. J. Pept. Protein Res. 45, 35-43.
123. Yao, X. J. Y., Goettlinger, H., Haseltine, W. A., and Cohen, E. A. (1992). Envelope glycoprotein and CD4 independence of Vpu-facilitated human immunodeficiency virus type 1 capsid export. J. Virol. 66, 5119-5126.
124. 2 in virions. J. Virol. 62, 2762-2772.
125. 2 integral membrane protein and expression at the infected-cell surface from cloned cDNA. J. Virol. 56, 502-511.
126. 1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses. Virology 176, 274-279.
127. 1 from influenza viruses by acid-dependent extraction with nonionic detergent. Virology 186, 324-330.